It's just the beginning for Spenda!, page-8954

First 8954 Last

Share
Profile

Follow
Moxiemoo

681 Posts.

159

06/02/23

16:12

Post #: 66099658
Share

Originally posted by CDO22 ↑

B2C is failing all over... The product is more challenging from a cashflow point of view, as the traditional very short term BNPL does not receive any income from the borrowers and all from the merchants, and compete with cards companies on fees. Some longer term BNPL add account fees paid by the borrowers. Still, they fundamentally earn an implied fixed rate while their funding costs are on a floating basis. So their profitability has been crushed as central banks have been hiking rate big time. B2B cashflow definition gives more pricing control to the lender.

B2C also seems to require a lot more spending in marketing. Looking at the listed ones gives you a crazy picture.... (far worse than Spenda!). And regulations are also coming for B2C, which will further constrain cashflows and add tot he costs.

Finally.... Apple will kill them all.... They're rolling out BNPL as part of Apple Pay, with pretty much no marketing needed. Bottom line, I think the B2C product will end up folding into the product offering of the bigger guys, who will spend less on marketing and tech.

B2B requires a lot of knowhow. It may look easy to roll out lending to small businesses, but to embed it into software packages, you need to know what you're doing in specialised verticals. There is a lot more room than in B2C to add value I think.

B2C as the final payment offering of a solution offered to a distributor, that includes servicing its suppliers and other "value added" pieces of software is possibly valuable, though will capture a small margin of the client flows, which I think will use mostly Apple Pay and the likes.

Expand

Appreciate the response

SPX Price at posting: 1.4¢ Sentiment: Buy Disclosure: Held
Upvote

0 Great analysis

Reply

Top Stories

FFM

Firefly positioned for copper growth in Canada ahead of resource update

CC9

Chariot Corp unveils plans for Black Mountain "pilot mine" in Wyoming, US; shares jump +20%

RCE

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

COD

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

ACW

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

There are more pages in this discussion • 6,506 more messages in this thread...

First 8954 Last

Add SPX (ASX) to my watchlist

(20min delay)
Last 1.0¢		Change -0.001(9.09%)		Mkt cap ! $46.03M

Open	High	Low	Value	Volume
1.1¢	1.1¢	1.0¢	$32.09K	2.922M

Buyers (Bids)

No.	Vol.	Price($)
18	7457325	1.0¢

Sellers (Offers)

Price($)	Vol.	No.
1.1¢	1759381	2

View Market Depth

No.	Vol.	Price($)
18	7457325	0.010
15	5925838	0.009
10	5358248	0.008
6	6232562	0.007
8	3397420	0.006

Price($)	Vol.	No.
0.011	1759381	2
0.012	5670492	11
0.013	9242645	10
0.014	8389378	13
0.015	7363083	7

Last trade - 16.10pm 03/10/2024 (20 minute delay)

SPX (ASX) Chart

It's just the beginning for Spenda!, page-8954

Firefly positioned for copper growth in Canada ahead of resource update

Chariot Corp unveils plans for Black Mountain "pilot mine" in Wyoming, US; shares jump +20%

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

It's just the beginning for Spenda!, page-8954

Top Stories

Firefly positioned for copper growth in Canada ahead of resource update

Chariot Corp unveils plans for Black Mountain "pilot mine" in Wyoming, US; shares jump +20%

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News